#206 - Llama 4, Nova Act, xAI buys X, PaperBench
Last Week in AI
Navigating the Complexities of External Funding in AI
This chapter explores Isomorphic Labs' innovative approach to AI-driven drug discovery and its successful $600 million funding round. It examines the origins of the company from DeepMind, its partnerships with pharmaceutical giants, and the complexities of funding within the Google ecosystem.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
